Related Experiment Video
Updated: Nov 11, 2025
08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
16.2K
Advanced Melanoma: Resistance Mechanisms to Current Therapies
Alexandra M Haugh1, April K S Salama2, Douglas B Johnson3
1Department of Medicine, Vanderbilt University Medical Center, 719 Thompson Lane, Suite 20400, Nashville, TN 37204, USA.
Hematology/Oncology Clinics of North America
|March 24, 2021
Summary
New melanoma treatments like immune checkpoint inhibitors and targeted therapies show promise but face resistance. This review explores mechanisms of acquired resistance to BRAF/MEK inhibitors and checkpoint inhibitors in melanoma patients.
Area of Science:
- Oncology
- Immunology
- Dermatology
Background:
- Metastatic melanoma management has been transformed by novel therapies.
- Immune checkpoint inhibitors and targeted therapies have improved patient outcomes.
- Treatment efficacy is often limited by innate or acquired resistance.
Purpose of the Study:
- To review mechanisms of acquired resistance to BRAF/MEK inhibitors in melanoma.
- To discuss insights into innate and acquired resistance to checkpoint inhibitors.
- To provide a comprehensive overview of therapeutic resistance in melanoma.
Main Methods:
- Literature review of recent studies on melanoma treatment resistance.
- Analysis of known and suspected resistance mechanisms.
- Synthesis of current understanding of BRAF/MEK and checkpoint inhibitor resistance.
Main Results:
- Identified various mechanisms contributing to acquired resistance to BRAF/MEK inhibitors.
- Highlighted emerging insights into innate and acquired resistance to checkpoint inhibitors.
- Detailed the challenges posed by treatment resistance in metastatic melanoma.
Conclusions:
- Understanding resistance mechanisms is crucial for overcoming treatment limitations.
- Further research into resistance pathways will guide the development of more effective therapies.
- Improved therapeutic strategies are needed to address resistance in melanoma patients.
Related Concept Videos
02:56Treatment Resistant Cancers
3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
02:57Targeted Cancer Therapies
8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.1K
01:27Tumor Immunotherapy
820
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
820
02:53Adaptive Mechanisms in Cancer Cells
6.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.1K
02:50Combination Therapies and Personalized Medicine
5.6K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K
02:49Cancer Therapies
8.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K